Loading viewer...
investor_presentation
Format: PDF investor_presentation
IOL Chemicals and Pharmaceuticals Limited presents Q1FY23 investor results for August 2022. The company is a leading manufacturer of APIs, intermediates, and specialty chemicals serving pharmaceuticals, inks, packaging, adhesives, coatings, and other industries. IOLCP operates world-class manufacturing facilities including a 17 MW captive co-generation unit.
investor_presentation
24 Pages
investor_presentation
22 Pages
Anika Therapeutics
Janison Education Group UNSW Global Acquisition Investor Presentation
investor_presentationinvestor_presentation
27 Pages
Janison Education Group Limited